SCHEMBL9339231

SCHEMBL9339231

CCCCc1ccc(C#N)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9340932 0.89
SCHEMBL9339294 0.85
SCHEMBL9337264 0.85 AGTR1 (0.49)
SCHEMBL9337738 0.84 PPARG (0.56)
SCHEMBL6499862 0.83 AGTR1 (0.49)
SCHEMBL9337763 0.83 AGTR1 (0.51)
SCHEMBL9341358 0.82
SCHEMBL9535272 0.82 AGTR1 (0.50)
Potassium SCHEMBL9535277 0.82 AGTR1 (0.50)
SCHEMBL12702246 0.82 AGTR1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5332750-A Treatment of hypertension, aldosteronism, cardiac insufficienc y MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1994-07-26 US disclosed